PRIME PRACTICE MANAGEMENT, INC. – Trademark Portfolio
Entity Type: 03
PRIME PRACTICE MANAGEMENT, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VIVIUS. The owner is based in Leawood, KS.
2112 W. 117th Street
Leawood, KS 66211
Showing of trademarks Trademarks
Trademark Classifications
PRIME PRACTICE MANAGEMENT, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does PRIME PRACTICE MANAGEMENT, INC. have?
PRIME PRACTICE MANAGEMENT, INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does PRIME PRACTICE MANAGEMENT, INC. file in?
PRIME PRACTICE MANAGEMENT, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are PRIME PRACTICE MANAGEMENT, INC.'s most well-known trademarks?
PRIME PRACTICE MANAGEMENT, INC.'s registered trademark portfolio includes well-known marks such as VIVIUS. These are among 1 currently registered trademark in the portfolio.
What is PRIME PRACTICE MANAGEMENT, INC.'s trademark registration success rate?
PRIME PRACTICE MANAGEMENT, INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.